Neisseria gonorrhoeae is a major public health problem globally, especially because the bacterium has developed resistance to most antimicrobials introduced for first-line treatment of gonorrhea. In the present study, 96 N. gonorrhoeae isolates with highlevel resistance to penicillin from 121 clinical isolates in Thailand were examined to investigate changes related to their plasmidmediated penicillin resistance and their molecular epidemiological relationships. A -lactamase (TEM) gene variant, bla , that may be a precursor in the transitional stage of a traditional bla TEM-1 gene into an extended-spectrum -lactamase (ESBL), possibly causing high resistance to all extended-spectrum cephalosporins in N. gonorrhoeae, was identified. Clonal analysis using multilocus sequence typing (MLST) and N. gonorrhoeae multiantigen sequence typing (NG-MAST) revealed the existence of a sexual network among patients from Japan and Thailand. Molecular analysis of the bla TEM-135 gene showed that the emergence of this allele might not be a rare genetic event and that the allele has evolved in different plasmid backgrounds, which results possibly indicate that it is selected due to antimicrobial pressure. The presence of the bla TEM-135 allele in the penicillinaseproducing N. gonorrhoeae population may call for monitoring for the possible emergence of ESBL-producing N. gonorrhoeae in the future. This study identified a bla TEM variant (bla TEM-135 ) that is a possible intermediate precursor for an ESBL, which warrants international awareness. N eisseria gonorrhoeae is the causative agent of gonorrhea, which is the second most prevalent bacterial sexually transmitted infection globally. During recent decades, N. gonorrhoeae has rapidly developed resistance to most classes of antimicrobials used for treatment of gonorrhea (4,6,17,18,20). Penicillinase-producing N. gonorrhoeae (PPNG), with plasmid-mediated high-level resistance to penicillin, was first reported in 1976 (1, 14) and has since been disseminated worldwide (2). The first gonococcal strain with high-level clinical resistance to ceftriaxone, which is the last remaining option for first-line gonorrhea treatment, was recently found in Japan and completely characterized (9, 11). However, the resistance to ceftriaxone was chromosomally mediated, and no extended-spectrum -lactamase (ESBL) has yet been identified in N. gonorrhoeae. If an ESBL did emerge in N. gonorrhoeae and spread internationally, gonorrhea would become an extremely serious public health problem. PPNG strains are rare in Japan, but these strains have remained highly prevalent in several other countries in Asia (19) and worldwide (20). Penicillin is still also used as the first-line drug in, e.g., some Pacific island countries and the northern part of Australia, because of maintained efficacy in the settings and its low cost.Although the -lactamase (TEM) gene of authentic PPNG is the bla TEM-1 allele, a recently isolated PPNG in Thailand possessed the bla TEM-135 allele, which differs from the bla TEM-1 allel...